About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Novel Compound Improves Antibiotics' Efficiency Against Superbugs

by Savitha C Muppala on February 18, 2012 at 6:35 PM
Font : A-A+

 Novel Compound Improves Antibiotics' Efficiency Against Superbugs

Chemists at the North Carolina State University have developed a compound which is capable of making existing antibiotics almost 16 times more effective against antibiotic-resistant superbugs.

These so-called superbugs are actually bacterial strains that produce an enzyme known as New Delhi metallo-B-lactamase (NDM-1).

Advertisement

Bacteria that produce this enzyme are practically impervious to antibiotics because NDM-1renders certain antibiotics unable to bind with their bacterial targets. Since NDM-1 is found in Gram-negative bacteria like K. pneumoniae, which causes pneumonia, urinary tract, and other common hospital-acquired infections, it is of particular concern.

"To begin with, there are fewer antibiotic options for treating infections caused by Gram-negative bacteria than for those caused by Gram-positive bacteria," said Dr. Roberta Worthington, NC State research assistant professor of chemistry.
Advertisement

"Gram-negative bacteria with the NDM-1 enzyme effectively neutralize the few weapons we have in our arsenal, making them especially difficult, if not impossible, to treat with existing antibiotic therapy," he explained.

Previously, NC State chemist Dr. Christian Melander had found that a compound derived from a class of molecules known as 2-aminoimidazoles "recharged" existing antibiotics, making them effective against Gram-positive antibiotic-resistant bacteria like the Staphylococcus strain MRSA.

So Melander, Worthington and graduate students Cynthia Bunders and Catherine Reed set to work on a variety of the compound that might prove similarly effective against their Gram-negative brethren.

Worthington and Melander have now described a compound that, when used in conjunction with the antibiotic imipenem, increased the antibiotic's effectiveness against the antibiotic-resistant K. pneumoniae 16-fold. The researchers believe that these early results are very promising for future treatments.

"We've demonstrated that we have the ability to take out the scariest superbug out there. Hopefully further research will allow us to make the compound even more effective, and make these infections little more than a nuisance," Melander claimed.

The research was published in ACS Medicinal Chemistry Letters.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
Long-Term Glycemic Control - A Better Measure of COVID-19 Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.


Recommended Reading
Cholera
Cholera is an infection of the small intestine and is caused by the bacterium Vibrio cholerae....
Typhoid and Paratyphoid Enteric Fevers
Typhoid and Paratyphoid Enteric Fevers are caused by bacteria called Salmonella typhi. Causes, ......
Expert Warns of Kidney Damage from Metals in Drugs
Kidney damage can result from metals used in medicine to cure rheumatoid arthritis, psychiatric ......
UBC Research Says 'Absence Seizures' in Children may be Prevented by New Drugs
A new class of drugs that completely suppress absence seizures in rats is now being tested in ......

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use